Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
iodixanol (visipaque) (1 trial)
iopamidol (Isovue) (1 trial)
Renal Insufficiency (Phase 4)
Trials (1 total)
Trial APIs (2 total)